Literature DB >> 1388979

Clonidine in the treatment of brainstem spasticity. Case report.

P R Sandford1, S E Spengler, K B Sawasky.   

Abstract

This report describes a patient who developed spasticity after a medullary infarct. No improvement in her spasticity was achieved by baclofen therapy and the side effects of the drug necessitated its gradual withdrawal. Recent reports of the success of clonidine in the management of spasticity due to spinal cord injury prompted an attempt at clonidine therapy. When clonidine therapy was initiated, the patient responded rapidly with both subjective and objective improvements in her spasticity. This case suggests a potential role for clonidine in the treatment of spasticity resulting from brainstem infarction.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1388979     DOI: 10.1097/00002060-199210000-00010

Source DB:  PubMed          Journal:  Am J Phys Med Rehabil        ISSN: 0894-9115            Impact factor:   2.159


  3 in total

Review 1.  Spasticity after stroke. Epidemiology and optimal treatment.

Authors:  C F O'Brien; L C Seeberger; D B Smith
Journal:  Drugs Aging       Date:  1996-11       Impact factor: 3.923

2.  Dexmedetomidine for acute baclofen withdrawal.

Authors:  Simon Morr; Christopher M Heard; Veetai Li; Renée M Reynolds
Journal:  Neurocrit Care       Date:  2015-04       Impact factor: 3.210

3.  Clonidine in the treatment of spasticity in patients with multiple sclerosis.

Authors:  O A Khan; M J Olek
Journal:  J Neurol       Date:  1995-10       Impact factor: 4.849

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.